CONTACT

Nicotinamide mononucleotide

NAD PRECURSOR

WHAT IT IS

NMN stands for nicotinamide mononucleotide, a molecule the body uses to make NAD. NAD is a coenzyme involved in cellular metabolism, and NMN is one of its precursors. No Jet Lag Night specifies beta-NMN.

WHY IT'S HERE

NMN is studied for its ability to raise NAD, a coenzyme involved in cellular energy metabolism. Small human trials report higher blood NAD levels, but this does not establish longevity or everyday performance benefits.

THE SHORT VERSION

May raise blood NAD levels; broader health benefits remain unproven.

From the current OVERT ingredient guide. Ingredient reference information; check the current product label for inclusion, amounts, directions and warnings. Research on an ingredient does not establish the effects of a finished OVERT formula.

Read the original guide and references ↗
Nicotinamide mononucleotide — original OVERT ingredient guide page
Research context and selected references
Human evidence supports changes in blood NAD. These small, short trials do not establish longevity or jet-lag benefits, or the efficacy of the complete blend.
  1. RANDOMIZED HUMAN TRIAL

    Okabe K et al. Oral Administration of Nicotinamide Mononucleotide Is Safe and Efficiently Increases Blood Nicotinamide Adenine Dinucleotide Levels in Healthy Subjects. Front Nutr. 2022;9:868640.

    Thirty healthy adults received NMN or placebo for twelve weeks. Whole-blood NAD increased with NMN; the study primarily addresses biochemical response and short-term tolerability, rather than travel recovery or long-term clinical outcomes.

    Read publication ↗ (Full paper: PMC9036060)

  2. RANDOMIZED HUMAN TRIAL

    Igarashi M, Nakagawa-Nagahama Y, Miura M, et al. Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men. npj Aging. 2022;8:5.

    doi:10.1038/s41514-022-00084-z. Forty-two older men were randomized to NMN or placebo. A supplier dispensing error excluded 22 participants from 12-week analyses, leaving 20. Blood NAD-related measures increased; the reduced sample and short duration limit wider clinical conclusions.

    Read publication ↗ (DOI: 10.1038/s41514-022-00084-z)

RESEARCH IN CONTEXT Ingredient studies do not establish the effects of the finished OVERT formulas. Forms, doses and study populations may differ. Technical sources describe identity or function. Source links are clickable in the digital guide. 56
Open source page 56 in the guide ↗

Contact OVERT

Questions about our products or ingredients?

Customer care

Explore the research

Understand the ingredients and the context behind them.

The ingredient library

The complete guide

The art and science of modern wellness, in detail.

Read the guidebook